A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Nearly $1 Million in PPE Is Donated to International Medical Corps for COVID-19 Response Efforts

In Partnership with the Medtronic Foundation, More Than 400,000 KN95 Respirators and 1.1 Million Surgical Masks to be Distributed to Healthcare Facilities Across Continental U.S. and Puerto Rico

October 9, 2020

Nearly $1 Million in PPE was donated to the International Medical Corps for COVID-19 response efforts to support its ongoing COVID-19 response efforts in the continental United States and Puerto Rico. The donation was made by Medtronic.

PPE Donations includes more than 1.1 million surgical masks and 408,000 KN95 respirators, which are being distributed by International Medical Corps, a long-time partner of the Medtronic Foundation, to more than 15 hospitals and health facilities chosen for their locations in COVID-19 hot spots, or directly to individuals as part of prevention efforts. In addition, these facilities serve underserved and underinsured communities, most at-risk and most affected by this pandemic, particularly as COVID-19 rates are increasing in some key locations.

“When an emergency strikes, Medtronic and the Medtronic Foundation are among the first to be there, helping to ensure that first responders have the resources they need,” said Erica Tavares, vice president of Institutional Partnerships and Philanthropy at International Medical Corps. “With their donation, frontline health workers across the country will be able to safely provide healthcare to communities most in need.”

“Doctors, nurses, and other frontline healthcare workers continue to do heroic work despite the risks to their personal health and the ongoing challenge of maintaining an adequate supply of personal protective equipment,” said John Liddicoat, M.D., executive vice president and president of the Americas Region at Medtronic. “We recognize and appreciate their tireless efforts and we are proud to support them, together with the Medtronic Foundation, with this donation.”

 

SourceMedtronic
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy